Tumor-stromal cell interaction under hypoxia increases the invasiveness of pancreatic cancer cells through the hepatocyte growth factor/c-Met pathway

被引:112
|
作者
Ide, Takao [1 ]
Kitajima, Yoshihiko [1 ]
Miyoshi, Atsushi [1 ]
Ohtsuka, Takao [1 ]
Mitsuno, Mayumi [1 ]
Ohtaka, Kazuma [1 ]
Koga, Yasuo [1 ]
Miyazaki, Kohji [1 ]
机构
[1] Saga Univ, Fac Med, Dept Surg, Saga 8498501, Japan
关键词
hypoxia; tumor-stromal interaction; pancreatic cancer; hepatocyte growth factor; c-Met;
D O I
10.1002/ijc.22178
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The hypoxic environment in tumor is reported to play an important role in pancreatic cancer progression. The interaction between stromal and cancer cells also contributes to the malignant behavior of pancreatic cancer. In the present study, we investigated whether hypoxic stimulation affects stromal as well as pancreatic cancer cells. Our findings demonstrated that hypoxia remarkably elevated the HIF-1 alpha expression in both pancreatic cancer (PK8) and fibroblast cells (MRC5). Hypoxic stimulation accelerated the invasive activity of PK8 cells, and invasiveness was thus further accelerated when the hypoxic PK8 cells were cultured with conditioned medium prepared from hypoxic MRC5 cells (hypoxic conditioned medium). MMP-2, MMP-7, MT1-MMP and c-Met expressions were increased in PK8 cells under hypoxia. Hypoxic stimulation also increased the hepatocyte growth factor (HGF) secretion from MRC5 cells, which led to an elevation of c-Met phosphorylation in PK8 cells. Conversely, the elevated cancer invasion, MMP activity and c-Met phosphorylation of PK8 cells were reduced by the removal of HGF from hypoxic conditioned medium. In immunohistochemical study, the HIF-1 alpha expression was observed in surrounding stromal as well as pancreatic cancer cells, thus indicating hypoxia exists in both of cancer and stromal cells. Moreover, the stromal HGF expression was found to significantly correlate with not only the stromal HIF-1a expression but also the c-Met expression in cancer cells. These results indicate that the hypoxic environment within stromal as well as cancer cells activates the HGF/c-Met system, thereby contributing to the aggressive invasive features of pancreatic cancer. (c) 2006 Wiley-Liss, Inc.
引用
收藏
页码:2750 / 2759
页数:10
相关论文
共 50 条
  • [41] Expression of hepatocyte growth factor and c-Met in non-small-cell lung cancer and association with lymphangiogenesis
    Zhang, Nan
    Xie, Fubo
    Gao, Wei
    Yu, Shuwen
    Qiu, Liyun
    Lin, Wenli
    Sun, Yuping
    Jia, Tanghong
    MOLECULAR MEDICINE REPORTS, 2015, 11 (04) : 2797 - 2804
  • [42] Reduction of stromal fibroblast-induced mammary tumor growth, by retroviral ribozyme transgenes to hepatocyte growth factor/scatter factor and its receptor, c-MET
    Jiang, WG
    Grimshaw, D
    Martin, TA
    Davies, G
    Parr, C
    Watkins, G
    Lane, J
    Abounader, R
    Laterra, J
    Mansel, RE
    CLINICAL CANCER RESEARCH, 2003, 9 (11) : 4274 - 4281
  • [43] THE FYN KINASE INTERACTS WITH HEPATOCYTE GROWTH FACTOR RECEPTOR c-MET UNDER HYPOXIA: IMPLICATIONS FOR HGF-SF/cMET SIGNALLING IN HCC CELLS
    Korhan, Peyda
    Bulut, Guelay
    Toylu, Ash
    Erdal, Esra
    Atabey, Nese
    IUBMB LIFE, 2009, 61 (03) : 369 - 369
  • [44] Olive Phenolics as c-Met Inhibitors: (-)-Oleocanthal Attenuates Cell Proliferation, Invasiveness, and Tumor Growth in Breast Cancer Models
    Akl, Mohamed R.
    Ayoub, Nehad M.
    Mohyeldin, Mohamed M.
    Busnena, Belnaser A.
    Foudah, Ahmed I.
    Liu, Yong-Yu
    El Sayed, Khalid A.
    PLOS ONE, 2014, 9 (05):
  • [45] Lysophosphatidic acid modulates c-Met redistribution and hepatocyte growth factor/c-Met signaling in human bronchial epithelial cells through PKC δ and E-cadherin
    Zhao, Yutong
    He, Donghong
    Stern, Randi
    Usatyuk, Peter V.
    Spannhake, Ernst Wm.
    Salgia, Ravi
    Natarajan, Viswanathan
    CELLULAR SIGNALLING, 2007, 19 (11) : 2329 - 2338
  • [46] A Potential Mechanism of Tumor Progression during Systemic Infections Via the Hepatocyte Growth Factor (HGF)/c-Met Signaling Pathway
    Tsujimoto, Hironori
    Horiguchi, Hiroyuki
    Matsumoto, Yusuke
    Takahata, Risa
    Shinomiya, Nariyoshi
    Yamori, Takao
    Miyazaki, Hiromi
    Ono, Satoshi
    Saitoh, Daizoh
    Kishi, Yoji
    Ueno, Hideki
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (07) : 1 - 13
  • [47] Hepatocyte growth factor and c-met inhibition by hepatic cell hypoxia - A potential mechanism for liver regeneration failure in experimental cirrhosis
    Corpechot, C
    Barbu, V
    Wendum, D
    Chignard, N
    Housset, C
    Poupon, R
    Rosmorduc, O
    AMERICAN JOURNAL OF PATHOLOGY, 2002, 160 (02): : 613 - 620
  • [48] HEPATOCYTE GROWTH FACTOR/ C-MET PATHWAY INHIBITION COMBINED WITH CHEMOTHERAPY RETARDS PRECURSOR PANINS AND POTENTIATES LOCAL IMMUNITY IN A TRANSGENIC MODEL OF EARLY PANCREATIC CANCER
    Mekapogu, Alpha Raj
    Xu, Zhihong
    Pothula, Srinivasa
    Perera, Chamini
    Pang, Tony
    Hosen, S. M. Zahid
    Damalanka, Vishnu C.
    Mahoney, Matthew
    Janetka, James W.
    Klampfer, Lidija
    Goldstein, David
    Pirola, Romano
    Wilson, Jeremy
    Apte, Minoti V.
    GASTROENTEROLOGY, 2021, 160 (06) : S45 - S45
  • [49] The role of hepatocyte growth factor and its receptor c-met in interactions between lymphocytes and stromal cells in secondary human lymphoid organs
    Skibinski, G
    Skibinska, A
    James, K
    IMMUNOLOGY, 2001, 102 (04) : 506 - 514
  • [50] HEPATOCYTE GROWTH FACTOR RECEPTOR (C-MET) SIGNALING PATHWAY REGULATES SYNOVIAL CELL PRODUCTION OF INFLAMMATORY MEDIATORS AND OSTEOBLAST DIFFERENTIATION
    Sekiguchi, M.
    Tsunemi, S.
    Kitano, S.
    Sano, H.
    Iwasaki, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 193 - 193